---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-081887"
form_type: "8-K"
ticker: null
cik: "0000874710"
company_name: "ALLIED HEALTHCARE PRODUCTS INC"
filed_at: "2023-07-18T23:59:59+00:00"
generated_at: "2026-06-13T07:24:00.375941+00:00"
event_type: "m_and_a"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Allied Healthcare completes $9.0M asset sale to Allied Medical in bankruptcy

## Summary
- Closed sale of STL and NY assets for aggregate purchase price of $8,988,974.
- Sales approved by Bankruptcy Court on June 30, 2023; consummated July 12, 2023.
- Chapter 11 case remains pending; full extent of liabilities unknown.
- Company warns common stock holders may receive no payment or distribution.
- Stalking horse bidder Allied Medical, LLC acquired both asset packages.

## SEC filing metadata
- accession: 0001104659-23-081887
- form_type: 8-K
- cik: 0000874710
- company_name: ALLIED HEALTHCARE PRODUCTS INC
- filed_at: 2023-07-18T23:59:59+00:00
- event_type: m_and_a
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 1.03, 2.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/874710/000110465923081887/0001104659-23-081887-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/874710/000110465923081887/tm2321491d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-081887
- JSON: https://secwatch.observer/filing/0001104659-23-081887.json
- Plain text: https://secwatch.observer/filing/0001104659-23-081887.txt

## Key facts
- M&A Transactions
  ALLIED HEALTHCARE PRODUCTS INC completed a disposition involving Allied Medical, LLC for $8,988,974 (closed 2023-07-12).
  - Action: disposition
  - Counterparty: Allied Medical, LLC
  - Consideration: $8,988,974
  - Closing: 2023-07-12
  source text: On July 12, 2023, the Company and the Purchaser consummated each of the STL Sale and the NY Sale. The aggregate final purchase price of the STL Assets and NY Assets, after all adjustments and reimbursements contemplated in the STL Purchase Agreement and NY Purchase Agreement was $8,988,974.
  evidence_url: https://www.sec.gov/Archives/edgar/data/874710/000110465923081887/0001104659-23-081887-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.